{"id":646,"date":"2021-06-15T14:03:47","date_gmt":"2021-06-15T12:03:47","guid":{"rendered":"https:\/\/translational-epigenetics.fr\/?p=646"},"modified":"2021-06-15T14:39:36","modified_gmt":"2021-06-15T12:39:36","slug":"new-article-cyclon-b-lymphomas","status":"publish","type":"post","link":"https:\/\/translational-epigenetics.fr\/index.php\/2021\/06\/15\/new-article-cyclon-b-lymphomas\/","title":{"rendered":"New article: CYCLON &#038; B lymphomas"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"646\" class=\"elementor elementor-646\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1dde326e elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1dde326e\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-30426412\" data-id=\"30426412\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-1369d5b1 elementor-widget elementor-widget-text-editor\" data-id=\"1369d5b1\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<!-- wp:paragraph -->\n<p>Our team just published a new clinical article, in which CYCLON is identified as a risk marker of refractory \/ relapse of B lymphomas (DLBCL) after the first line of treatment by R-CHOP.<\/p>\n<!-- \/wp:paragraph --><!-- wp:paragraph -->\n<p>Link to the main article: <a href=\"https:\/\/journals.lww.com\/hemasphere\/Fulltext\/2021\/07000\/Extranucleolar_CYCLON_Staining_Pattern_Is_Strongly.3.aspx\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n<!-- \/wp:paragraph --><!-- wp:image {\"id\":647,\"sizeSlug\":\"large\",\"linkDestination\":\"none\"} -->\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/journals.lww.com\/hemasphere\/Fulltext\/2021\/07000\/Extranucleolar_CYCLON_Staining_Pattern_Is_Strongly.3.aspx\" target=\"_blank\" rel=\"noopener\"><img fetchpriority=\"high\" decoding=\"async\" width=\"622\" height=\"248\" class=\"wp-image-647\" src=\"https:\/\/translational-epigenetics.fr\/wp-content\/uploads\/2021\/06\/Capture-de\u0301cran-2021-06-15-a\u0300-13.58.02.png\" alt=\"\" srcset=\"https:\/\/translational-epigenetics.fr\/wp-content\/uploads\/2021\/06\/Capture-de\u0301cran-2021-06-15-a\u0300-13.58.02.png 622w, https:\/\/translational-epigenetics.fr\/wp-content\/uploads\/2021\/06\/Capture-de\u0301cran-2021-06-15-a\u0300-13.58.02-300x120.png 300w\" sizes=\"(max-width: 622px) 100vw, 622px\" \/><\/a><\/figure>\n<!-- \/wp:image -->\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Our team just published a new clinical article, in which CYCLON is identified as a risk marker of refractory \/ relapse of B lymphomas (DLBCL) after the first line of treatment by R-CHOP. Link to the main article: here.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-646","post","type-post","status-publish","format-standard","hentry","category-non-classe"],"_links":{"self":[{"href":"https:\/\/translational-epigenetics.fr\/index.php\/wp-json\/wp\/v2\/posts\/646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/translational-epigenetics.fr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/translational-epigenetics.fr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/translational-epigenetics.fr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/translational-epigenetics.fr\/index.php\/wp-json\/wp\/v2\/comments?post=646"}],"version-history":[{"count":8,"href":"https:\/\/translational-epigenetics.fr\/index.php\/wp-json\/wp\/v2\/posts\/646\/revisions"}],"predecessor-version":[{"id":664,"href":"https:\/\/translational-epigenetics.fr\/index.php\/wp-json\/wp\/v2\/posts\/646\/revisions\/664"}],"wp:attachment":[{"href":"https:\/\/translational-epigenetics.fr\/index.php\/wp-json\/wp\/v2\/media?parent=646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/translational-epigenetics.fr\/index.php\/wp-json\/wp\/v2\/categories?post=646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/translational-epigenetics.fr\/index.php\/wp-json\/wp\/v2\/tags?post=646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}